Market Overview:
The global pepsin market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for pepsin in pharmaceuticals, inspection & quarantine, health supplements, and other applications. The high activity type of pepsin is expected to dominate the market during the forecast period. North America is expected to lead the global pepsin market during the forecast period owing to technological advancements and growing demand for processed food products in this region.
Product Definition:
Pepsin is a digestive enzyme that helps break down proteins into smaller peptide chains and amino acids. Pepsin is secreted by the stomach's chief cells and activated by gastric acid. It plays an important role in the digestion of meat, dairy products, and other protein-rich foods.
High Activity (Min. 1:10000):
High activity is a term used for proteins that are capable of inducing biological activities such as proteolytic and phospholipase activities. Proteins with high activity have the ability to hydrolyze peptide bonds in a short time, thus allowing them to be used as digestive enzymes. The most common sources of high-activity protein include pancreas, stomach, bile ducts and gallbladder.
Low Activity (Below 1:10000):
Low activity is a new term in the world of biotechnology and it has been used for the first time to describe an enzyme that catalyzes chemical reactions at very low rates. The enzyme, which was discovered by chance, has turned out to be of great importance in research on protein digestion and blood coagulation. This discovery led scientists to believe that there may be many more such enzymes in nature waiting to be identified.
Application Insights:
The other application segment includes food and beverages, personal care products, textile processing, pulp and paper manufacturing. The demand for pepsin in these applications is expected to be driven by its use in the manufacture of health supplements as well as other dietary supplements. Pepsin is used for manufacturing a variety of health supplement formulations including chewable tablets, capsules (bland), liquids (concentrated or not) and powder blends which are sold over-the-counter without prescription.
In addition to this, the product finds extensive usage in pharmaceuticals owing to its high purity level which helps enhance drug efficacy while reducing adverse effects associated with conventional active ingredients.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to rapid economic growth and increasing population in China and India. In addition, rising awareness about Pepsin products among end-users is anticipated to fuel demand for Pepsins during the forecast period.
Europe accounted for a significant share of revenue in 2017 due to high prevalence of digestive system diseases coupled with growing geriatric population base in Germany, France and Italy (GII). Moreover, stringent government regulations regarding quality standards are likely boost regional product demand over the coming years.
North America also held a substantial share owing to presence of major pharmaceutical companies such as Pfizer Inc., Merck & Co., Johnson & Johnson Ltd., Bristol-Myers Squibb Company among others that manufacture Pepsins products on large scale basis thereby contributing significantly towards regional revenue generation capacity.
Growth Factors:
- Increasing demand for processed and packaged food products
- Rising awareness about the benefits of digestive enzymes
- Growing number of people with digestive problems or disorders
- Increasing use of Pepsin in dietary supplements and functional foods
- Technological advancements in enzyme production
Scope Of The Report
Report Attributes
Report Details
Report Title
Pepsin Market Research Report
By Type
High Activity (Min. 1:10000), Low Activity (Below 1:10000)
By Application
Pharmaceuticals, Inspection & Quarantine, Health Supplements, Other
By Companies
A. Constantino & C.(Italy), Mitushi Pharma(India), Biolaxi (India), Kin Master(Brazil), Feideli Pharmaceutical(China), Sichuan Deebio Pharmaceutical(China), Chongqing Qquanxin Xiangsheng(China), Sichuan Biosyn Pharmaceutical(China)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
131
Number of Tables & Figures
92
Customization Available
Yes, the report can be customized as per your need.
Global Pepsin Market Report Segments:
The global Pepsin market is segmented on the basis of:
Types
High Activity (Min. 1:10000), Low Activity (Below 1:10000)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceuticals, Inspection & Quarantine, Health Supplements, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- A. Constantino & C.(Italy)
- Mitushi Pharma(India)
- Biolaxi (India)
- Kin Master(Brazil)
- Feideli Pharmaceutical(China)
- Sichuan Deebio Pharmaceutical(China)
- Chongqing Qquanxin Xiangsheng(China)
- Sichuan Biosyn Pharmaceutical(China)
Highlights of The Pepsin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- High Activity (Min. 1:10000)
- Low Activity (Below 1:10000)
- By Application:
- Pharmaceuticals
- Inspection & Quarantine
- Health Supplements
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pepsin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pepsin is a digestive enzyme that helps break down food in the stomach.
Some of the major players in the pepsin market are A. Constantino & C.(Italy), Mitushi Pharma(India), Biolaxi (India), Kin Master(Brazil), Feideli Pharmaceutical(China), Sichuan Deebio Pharmaceutical(China), Chongqing Qquanxin Xiangsheng(China), Sichuan Biosyn Pharmaceutical(China).
The pepsin market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pepsin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pepsin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pepsin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pepsin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pepsin Market Size & Forecast, 2020-2028
4.5.1 Pepsin Market Size and Y-o-Y Growth
4.5.2 Pepsin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 High Activity (Min. 1:10000)
5.2.2 Low Activity (Below 1:10000)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceuticals
6.2.2 Inspection & Quarantine
6.2.3 Health Supplements
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pepsin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pepsin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 High Activity (Min. 1:10000)
9.6.2 Low Activity (Below 1:10000)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceuticals
9.10.2 Inspection & Quarantine
9.10.3 Health Supplements
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 High Activity (Min. 1:10000)
10.6.2 Low Activity (Below 1:10000)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceuticals
10.10.2 Inspection & Quarantine
10.10.3 Health Supplements
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 High Activity (Min. 1:10000)
11.6.2 Low Activity (Below 1:10000)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceuticals
11.10.2 Inspection & Quarantine
11.10.3 Health Supplements
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 High Activity (Min. 1:10000)
12.6.2 Low Activity (Below 1:10000)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceuticals
12.10.2 Inspection & Quarantine
12.10.3 Health Supplements
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 High Activity (Min. 1:10000)
13.6.2 Low Activity (Below 1:10000)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceuticals
13.10.2 Inspection & Quarantine
13.10.3 Health Supplements
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pepsin Market: Competitive Dashboard
14.2 Global Pepsin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 A. Constantino & C.(Italy)
14.3.2 Mitushi Pharma(India)
14.3.3 Biolaxi (India)
14.3.4 Kin Master(Brazil)
14.3.5 Feideli Pharmaceutical(China)
14.3.6 Sichuan Deebio Pharmaceutical(China)
14.3.7 Chongqing Qquanxin Xiangsheng(China)
14.3.8 Sichuan Biosyn Pharmaceutical(China)
